These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19502977)

  • 21. The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock.
    Rokyta R; Pechman V
    Neuro Endocrinol Lett; 2006; 27(1-2):121-7. PubMed ID: 16648778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levosimendan reduces cardiac troponin release after cardiac surgery: a meta-analysis of randomized controlled studies.
    Zangrillo A; Biondi-Zoccai G; Mizzi A; Bruno G; Bignami E; Gerli C; De Santis V; Tritapepe L; Landoni G
    J Cardiothorac Vasc Anesth; 2009 Aug; 23(4):474-8. PubMed ID: 19217315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levosimendan in aortic valve surgery: cardiac performance and recovery.
    Järvelä K; Maaranen P; Sisto T; Ruokonen E
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):693-8. PubMed ID: 18922425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective observational study of levosimendan and weaning of difficult-to-wean ventilator dependent intensive care patients.
    Sterba M; Banerjee A; Mudaliar Y
    Crit Care Resusc; 2008 Sep; 10(3):182-6. PubMed ID: 18798715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of levosimendan in the treatment of heart failure.
    Lehtonen L; Põder P
    Ann Med; 2007; 39(1):2-17. PubMed ID: 17364447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levosimendan for low cardiac output: a pediatric experience.
    Egan JR; Clarke AJ; Williams S; Cole AD; Ayer J; Jacobe S; Chard RB; Winlaw DS
    J Intensive Care Med; 2006; 21(3):183-7. PubMed ID: 16672640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance.
    Tsagalou EP; Kanakakis J; Anastasiou-Nana MI; Drakos SG; Ntalianis AS; Malliaras K; Lazaris N; Katsaros F; Nanas JN
    Acute Card Care; 2009; 11(2):99-106. PubMed ID: 19353405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of levosimendan on the energy balance: preclinical and clinical evidence.
    Nieminen MS; Pollesello P; Vajda G; Papp Z
    J Cardiovasc Pharmacol; 2009 Apr; 53(4):302-10. PubMed ID: 19276987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levosimendan in cardiogenic shock: the magic drug for every patient?
    Smetana P; Geppert A
    Crit Care Med; 2007 Dec; 35(12):2862-4. PubMed ID: 18043208
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of levosimendan in normodynamic endotoxaemia: a controlled experimental study.
    Dubin A; Maskin B; Murias G; Pozo MO; Sottile JP; Barán M; Edul VS; Canales HS; Estenssoro E
    Resuscitation; 2006 May; 69(2):277-86. PubMed ID: 16458408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peri-operative Levosimendan in Patients Undergoing Cardiac Surgery: An Overview of the Evidence.
    Shi WY; Li S; Collins N; Cottee DB; Bastian BC; James AN; Mejia R
    Heart Lung Circ; 2015 Jul; 24(7):667-72. PubMed ID: 25862519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction.
    Christoph A; Prondzinsky R; Russ M; Janusch M; Schlitt A; Lemm H; Reith S; Werdan K; Buerke M
    Acute Card Care; 2008; 10(1):49-57. PubMed ID: 17924229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levosimendan: new indications and evidence for reduction in perioperative mortality?
    Pisano A; Monti G; Landoni G
    Curr Opin Anaesthesiol; 2016 Aug; 29(4):454-61. PubMed ID: 27168089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis.
    Harrison RW; Hasselblad V; Mehta RH; Levin R; Harrington RA; Alexander JH
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1224-32. PubMed ID: 24050857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inoprotection: the perioperative role of levosimendan.
    Soeding PE; Royse CF; Wright CE; Royse AG; Angus JA
    Anaesth Intensive Care; 2007 Dec; 35(6):845-62. PubMed ID: 18084975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inotropic, vasodilating and preconditioning actions of levosimendan in the heart.
    Meyer K; Schipke JD; Klocke RC; Gams E; Korbmacher B
    Thorac Cardiovasc Surg; 2008 Oct; 56(7):379-85. PubMed ID: 18810693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
    Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M
    Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The vasodilatory effects of levosimendan on the human internal mammary artery.
    Montes FR; Echeverri D; Buitrago L; Ramírez I; Giraldo JC; Maldonado JD; Umaña JP
    Anesth Analg; 2006 Nov; 103(5):1094-8. PubMed ID: 17056938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cardioprotective effects of levosimendan: preclinical and clinical evidence.
    Pollesello P; Papp Z
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):257-63. PubMed ID: 17878752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levosimendan in cardiac surgery: a unique drug for the treatment of perioperative left ventricular dysfunction or just another inodilator searching for a clinical application?
    Pagel PS
    Anesth Analg; 2007 Apr; 104(4):759-61. PubMed ID: 17377077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.